vimarsana.com
Home
Live Updates
CARMAT Announces the Restart of Production and Confirms the
CARMAT Announces the Restart of Production and Confirms the
CARMAT Announces the Restart of Production and Confirms the Objective of Resuming Implants of its Aeson Artificial Heart in October 2022
Regulatory News: CARMAT (FR0010907956, ALCAR) (Paris:ALCAR), the designer and developer of the world's most advanced total artificial heart, aiming to fulfill an unmet medical need by providing a
Related Keywords
France ,
United States ,
Germany ,
Bois Darcy ,
Bourgogne ,
Paris ,
France General ,
Villacoublay ,
French ,
Dusan Oresansky ,
Enregistrement Universel ,
Caroline Carmagnol ,
Linkedin ,
European Union ,
Food Drug Administration ,
Regulatory News ,
Chief Executive Officer ,
French Medtech ,
Early Feasibility Study ,
Euronext Growth ,
Universal Registration Document ,
Des March ,
Executive Officer ,
Financial Officer ,
Carmat ,
Nnounces ,
Restart ,
Production ,
Onfirms ,
Objective ,
Presuming ,
Implants ,
Beeson ,
Rtificial ,
Heart ,
October ,
022 ,